The use of metformin, insulin, sulphonylureas, and thiazolidinediones and the risk of fracture: Systematic review and meta-analysis of observational studies
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
The use of metformin, insulin, sulphonylureas, and thiazolidinediones and the risk of fracture: Systematic review and meta-analysis of observational studies
Authors
Keywords
-
Journal
Obesity Reviews
Volume -, Issue -, Pages -
Publisher
Wiley
Online
2019-06-28
DOI
10.1111/obr.12885
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Fracture Risk After Initiation of Use of Canagliflozin
- (2019) Michael Fralick et al. ANNALS OF INTERNAL MEDICINE
- Diabetes mellitus and the risk of fractures at specific sites: a meta-analysis
- (2019) Hao Wang et al. BMJ Open
- Risk of fracture with dipeptidyl peptidase-4 inhibitors, glucagon-like peptide-1 receptor agonists, or sodium-glucose cotransporter-2 inhibitors in real-world use: systematic review and meta-analysis of observational studies
- (2019) K. Hidayat et al. OSTEOPOROSIS INTERNATIONAL
- Sulfonylureas as Initial Treatment for Type 2 Diabetes and the Risk of Severe Hypoglycemia
- (2018) Oriana Yu et al. AMERICAN JOURNAL OF MEDICINE
- Effects of metformin, rosiglitazone and insulin on bone metabolism in patients with type 2 diabetes
- (2018) Tore Bjerregaard Stage et al. BONE
- Glucagon-like peptide-1 receptor agonists and fracture risk: a network meta-analysis of randomized clinical trials
- (2018) Y. S. Zhang et al. OSTEOPOROSIS INTERNATIONAL
- Sodium-glucose cotransporter 2 inhibitors and fracture risk in patients with type 2 diabetes mellitus: A systematic literature review and Bayesian network meta-analysis of randomized controlled trials
- (2018) Md Azharuddin et al. DIABETES RESEARCH AND CLINICAL PRACTICE
- Diabetes pharmacotherapy and effects on the musculoskeletal system
- (2018) Evangelia Kalaitzoglou et al. DIABETES-METABOLISM RESEARCH AND REVIEWS
- Association between glycemic control and risk of fracture in diabetic patients: A nested case-control study
- (2018) Janina Vavanikunnel et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Sodium glucose cotransporter 2 inhibitors and risk of serious adverse events: nationwide register based cohort study
- (2018) Peter Ueda et al. BMJ-British Medical Journal
- Clinical Fractures Among Older Men With Diabetes Are Mediated by Diabetic Complications
- (2017) Richard H Lee et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- The effect of insulin on bone mineral density among women with type 2 diabetes: a SWAN Pharmacoepidemiology study
- (2017) K. Ruppert et al. OSTEOPOROSIS INTERNATIONAL
- Severe hypoglycemia and hip fracture in patients with type 2 diabetes: a nationwide population-based cohort study
- (2017) Y. C. Hung et al. OSTEOPOROSIS INTERNATIONAL
- Effect of anti-diabetic drugs on bone metabolism: Evidence from preclinical and clinical studies
- (2017) Mohammad Adil et al. Pharmacological Reports
- The global economic burden of diabetes in adults aged 20–79 years: a cost-of-illness study
- (2017) Christian Bommer et al. Lancet Diabetes & Endocrinology
- Effects of Lobeglitazone, a Novel Thiazolidinedione, on Bone Mineral Density in Patients with Type 2 Diabetes Mellitus over 52 Weeks
- (2017) Soo Lim et al. Diabetes & Metabolism Journal
- Insulin use and Excess Fracture Risk in Patients with Type 2 Diabetes: A Propensity-Matched cohort analysis
- (2017) Eladio Losada-Grande et al. Scientific Reports
- DPP-4 inhibitor therapy and bone fractures in people with Type 2 diabetes – A systematic review and meta-analysis
- (2016) Jil Mamza et al. DIABETES RESEARCH AND CLINICAL PRACTICE
- Type 2 Diabetes and Risk of Hip Fractures and Non-Skeletal Fall Injuries in the Elderly: A Study From the Fractures and Fall Injuries in the Elderly Cohort (FRAILCO)
- (2016) Märit Wallander et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Does Sitagliptin Affect the Rate of Osteoporotic Fractures in Type 2 Diabetes? Population-Based Cohort Study
- (2016) Sumit R. Majumdar et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Worldwide trends in diabetes since 1980: a pooled analysis of 751 population-based studies with 4·4 million participants
- (2016) LANCET
- Risk of fractures and diabetes medications: a nationwide cohort study
- (2016) H. J. Choi et al. OSTEOPOROSIS INTERNATIONAL
- Minimizing Hypoglycemia in Diabetes
- (2015) DIABETES CARE
- Sulfonylureas and risk of falls and fractures among nursing home residents with type 2 diabetes mellitus
- (2015) Kate L. Lapane et al. DIABETES RESEARCH AND CLINICAL PRACTICE
- The effect of thiazolidinediones on bone mineral density and bone turnover: systematic review and meta-analysis
- (2015) Emma O. Billington et al. DIABETOLOGIA
- Sulfonylurea Use and Risk of Hip Fractures Among Elderly Men and Women with Type 2 Diabetes
- (2015) Swapnil N. Rajpathak et al. DRUGS & AGING
- Effects of TZD Use and Discontinuation on Fracture Rates in ACCORD Bone Study
- (2015) Ann V. Schwartz et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Risk of fracture with thiazolidinediones: An updated meta-analysis of randomized clinical trials
- (2014) Zhong-Ning Zhu et al. BONE
- Fracture risk in diabetic elderly men: the MrOS study
- (2014) Nicola Napoli et al. DIABETOLOGIA
- Evaluation of the anti-osteoporotic effects of metformin and sitagliptin in postmenopausal diabetic women
- (2014) Sahar Kamal Hegazy JOURNAL OF BONE AND MINERAL METABOLISM
- Reduced risk of hypoglycemia with once-daily glargine versus twice-daily NPH and number needed to harm with NPH to demonstrate the risk of one additional hypoglycemic event in type 2 diabetes: Evidence from a long-term controlled trial
- (2014) Julio Rosenstock et al. JOURNAL OF DIABETES AND ITS COMPLICATIONS
- National Estimates of Insulin-Related Hypoglycemia and Errors Leading to Emergency Department Visits and Hospitalizations
- (2014) Andrew I. Geller et al. JAMA Internal Medicine
- Cardiovascular disease, chronic kidney disease, and diabetes mortality burden of cardiometabolic risk factors from 1980 to 2010: a comparative risk assessment
- (2014) Lancet Diabetes & Endocrinology
- Metformin and the Risk of Cancer: Time-related biases in observational studies
- (2012) S. Suissa et al. DIABETES CARE
- Association between hypoglycaemic events and fall-related fractures in Medicare-covered patients with type 2 diabetes
- (2012) S. S. Johnston et al. DIABETES OBESITY & METABOLISM
- Hospitalised hip fracture risk with rosiglitazone and pioglitazone use compared with other glucose-lowering drugs
- (2012) H. M. Colhoun et al. DIABETOLOGIA
- Distinct effects of pioglitazone and metformin on circulating sclerostin and biochemical markers of bone turnover in men with type 2 diabetes mellitus
- (2012) A H van Lierop et al. EUROPEAN JOURNAL OF ENDOCRINOLOGY
- Bone, sweet bone—osteoporotic fractures in diabetes mellitus
- (2012) Christine Hamann et al. Nature Reviews Endocrinology
- Fracture Incidence and Risk of Osteoporosis in Female Type 2 Diabetic Patients in Korea
- (2012) Jong Kwan Jung et al. Diabetes & Metabolism Journal
- Diabetic peripheral neuropathy is highly associated with nontraumatic fractures in Korean patients with type 2 diabetes mellitus
- (2011) Ji-Hyun Kim et al. CLINICAL ENDOCRINOLOGY
- Rosiglitazone and pioglitazone increase fracture risk in women and men with type 2 diabetes
- (2010) R. E. Aubert et al. DIABETES OBESITY & METABOLISM
- Thiazolidinediones and Fractures: Evidence from Translating Research into Action for Diabetes
- (2010) Dori Bilik et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Thiazolidinedione Use and the Longitudinal Risk of Fractures in Patients with Type 2 Diabetes Mellitus
- (2010) Zeina A. Habib et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Thiazolidinediones and Fractures in Men and Women
- (2009) Colin R. Dormuth et al. ARCHIVES OF INTERNAL MEDICINE
- The association between thiazolidinediones and hospitalisation for fracture in type 2 diabetic patients: a Taiwanese population-based nested case–control study
- (2009) F.-Y. Hsiao et al. DIABETOLOGIA
- A Cohort Study of Thiazolidinediones and Fractures in Older Adults with Diabetes
- (2009) Daniel H. Solomon et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Effect of Rosiglitazone, Metformin, and Glyburide on Bone Biomarkers in Patients with Type 2 Diabetes
- (2009) Bernard Zinman et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Variation in risk factors for fractures at different sites
- (2009) Jennifer L. Kelsey et al. Current Osteoporosis Reports
- Use of Thiazolidinediones and Fracture Risk
- (2008) Christian Meier et al. ARCHIVES OF INTERNAL MEDICINE
- Long-term use of thiazolidinediones and fractures in type 2 diabetes: a meta-analysis
- (2008) Y. K. Loke et al. CANADIAN MEDICAL ASSOCIATION JOURNAL
- Rosiglitazone-Associated Fractures in Type 2 Diabetes: An analysis from A Diabetes Outcome Progression Trial (ADOPT)
- (2008) S. E. Kahn et al. DIABETES CARE
- Fracture Risk in Type 2 Diabetes: Update of a Population-Based Study
- (2008) L Joseph Melton et al. JOURNAL OF BONE AND MINERAL RESEARCH
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started